Stockreport

Travere Therapeutics (TVTX): Unprofitable But Forecast 67% Annual Earnings Growth Challenges Bearish Narratives [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF However, the outlook for earnings is robust, with forecasts calling for 66.89% annual earnings growth and a transition to profitability within the next three years. This [Read more]